Literature DB >> 9299160

Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts.

S Akiyama1, T Katagiri, M Namiki, N Yamaji, N Yamamoto, K Miyama, H Shibuya, N Ueno, J M Wozney, T Suda.   

Abstract

Bone morphogenetic protein-2 (BMP-2), a member of transforming growth factor-beta superfamily, inhibits the terminal differentiation of C2C12 myoblasts and changes their differentiation pathway into cells expressing osteoblast phenotypes such as alkaline phosphatase (ALP) activity and osteocalcin production (Katagiri et al., 1994, J. Cell Biol. 127, 1755-1766). Two type I receptors for BMP-2 (BMPR-IA and BMPR-IB) have been cloned, but the role of the respective receptors in signal transduction is not clear. In the present study, we examined the signal transduction of BMP-2 in C2C12 cells using constitutively activated mutant BMPR-IA and BMPR-IB. C2C12 cells expressed BMPR-IA and BMPR-II mRNAs, but not BMPR-IB mRNA at detectable levels in Northern blotting. When mutated BMPR-IA and BMPR-IB were transiently transfected into C2C12 cells, both BMPR-IA and BMPR-IB similarly induced ALP activity in the absence of BMP-2. We also established subclonal cell lines of C2C12 cells by stably transfecting mutated BMPR-IB. When the mutated BMPR-IB-transfected cells were cultured in medium with low serum (differentiation medium) without BMP-2, the cells differentiated into ALP-positive mononuclear cells and not into myosin heavy chain-positive myotubes. These mutated BMPR-IB-transfected cells expressed ALP activity and osteocalcin mRNA in a time-dependent manner, but neither muscle creatine kinase nor myogenin mRNAs. These results indicate that the mutated BMP-2 type I receptors can constitutively transduce BMP-2 signals in the absence of the ligand in C2C12 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299160     DOI: 10.1006/excr.1997.3680

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  Geminin cooperates with Polycomb to restrain multi-lineage commitment in the early embryo.

Authors:  Jong-Won Lim; Pamela Hummert; Jason C Mills; Kristen L Kroll
Journal:  Development       Date:  2010-11-23       Impact factor: 6.868

2.  BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties.

Authors:  Michael Rendl; Lisa Polak; Elaine Fuchs
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

3.  ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma.

Authors:  G H Su; R Bansal; K M Murphy; E Montgomery; C J Yeo; R H Hruban; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 4.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

5.  BBP-Functionalized Biomimetic Nanofibrous Scaffold Can Capture BMP2 and Promote Osteogenic Differentiation.

Authors:  Qingqing Yao; Eric S Sandhurst; Yangxi Liu; Hongli Sun
Journal:  J Mater Chem B       Date:  2017-05-30       Impact factor: 6.331

6.  Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins.

Authors:  Junya Nojima; Kazuhiro Kanomata; Yumi Takada; Toru Fukuda; Shoichiro Kokabu; Satoshi Ohte; Takatora Takada; Tohru Tsukui; Takamasa S Yamamoto; Hiroki Sasanuma; Katsumi Yoneyama; Naoto Ueno; Yasushi Okazaki; Ryutaro Kamijo; Tetsuya Yoda; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

7.  Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.

Authors:  M Fujii; K Takeda; T Imamura; H Aoki; T K Sampath; S Enomoto; M Kawabata; M Kato; H Ichijo; K Miyazono
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

8.  Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo.

Authors:  S Iemura; T S Yamamoto; C Takagi; H Uchiyama; T Natsume; S Shimasaki; H Sugino; N Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.

Authors:  Toru Fukuda; Masakazu Kohda; Kazuhiro Kanomata; Junya Nojima; Atsushi Nakamura; Jyunji Kamizono; Yasuo Noguchi; Kiyofumi Iwakiri; Takeo Kondo; Junichi Kurose; Ken-ichi Endo; Takeshi Awakura; Junichi Fukushi; Yasuharu Nakashima; Tomohiro Chiyonobu; Akira Kawara; Yoshihiro Nishida; Ikuo Wada; Masumi Akita; Tetsuo Komori; Konosuke Nakayama; Akira Nanba; Yuichi Maruki; Tetsuya Yoda; Hiroshi Tomoda; Paul B Yu; Eileen M Shore; Frederick S Kaplan; Kohei Miyazono; Masaru Matsuoka; Kenji Ikebuchi; Akira Ohtake; Hiromi Oda; Eijiro Jimi; Ichiro Owan; Yasushi Okazaki; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

Review 10.  The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-06       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.